Advertisement

Related Videos

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Deborah Collyar: What's In It for Patients?

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Opportunities to Optimize Cancer Policies Panel Discussion

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Advertisement

Advertisement




Oct
20
Today In Oncology
Claudia Henschke, PhD, MD Finding Lung Cancer in Time
Starting Surveillance Colonoscopy After High-Risk Adenoma Removal When Is the Right Time
Evolving Strategies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
AI Model Based on Facial Image Analysis Estimates Biological Age and Mortality Risk in Patients With Cancer
Community Oncology Practices Bring Advances in Cancer Testing and Treatment Closer to Patients
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo